Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers

American Journal of Psychiatry

Volumn 158, Issue 3, 2001, Pages 383-389

  Volkow, N D ^a   Chang, L ^a   Wang, G J ^a   Fowler, J S ^a   Franceschi, D ^a   Sedler, M J ^a   Gatley, S J ^a   Hitzemann, R ^a   Ding, Y S ^a   Wong, C ^a   Logan, J ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; FLUORODEOXYGLUCOSE F 18; GLUCOSE; METHAMPHETAMINE;

ADULT; ARTICLE; BRAIN CORTEX; BRAIN FUNCTION; BRAIN MAPPING; BRAIN METABOLISM; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DETOXIFICATION; DRUG DEPENDENCE; FEMALE; GLUCOSE METABOLISM; HUMAN; IMAGE ANALYSIS; MALE; METABOLIC RATE; NEUROPSYCHOLOGICAL TEST; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SUBSTANCE ABUSE;

ADULT; BRAIN; CEREBRAL CORTEX; CORPUS STRIATUM; DOPAMINE; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; MALE; METHAMPHETAMINE; SEX FACTORS; SUBSTANCE-RELATED DISORDERS; THALAMUS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0035098208     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.158.3.383     Document Type: Article

References (47)

1. Effects of repeated methamphetamine administration on methamphetamine self-administration in rhesus monkeys
2. Methamphetamine abuse alert
3. Human methamphetamine-related fatalities in Taiwan during 1991-1996
4. Neurotoxicity of amphetamines and their metabolites
5. Long-term effects of repeated methylamphetamine administration on monoamine neurons in the rhesus monkey brain
6. Methamphetamine and methylenedioxymethamphetamine neurotoxicity: Possible mechanisms of cell destruction
7. Motor impairments after methamphetamine-induced neurotoxicity in the rat
8. Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: A regional study
9. Alpha-methyltyrosine blocks methylamphetamine-induced degeneration in the rat somatosensory cortex
10. Histological and ultrastructural evidence that D-amphetamine causes degeneration in neostriatum and frontal cortex of rats
11. In vivo evidence that methamphetamine abuse produces long lasting changes in dopamine transporters in human brain
12. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users
13. 11C]WIN-35,428
14. Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: A re-examination
15. Neurochemical imaging of Alzheimer's disease and other degenerative dementias
16. Metabolic and clinical correlates of acute ischemic infarction
17. Association of lower dopamine transporter levels with psychomotor impairment in methamphetamine abusers
18. The CES-D Scale: A self-report depression scale for research in the general population
19. Functional significance of ventricular enlargement and cortical atrophy in normals and alcoholics as assessed by PET, MRI and neuropsychological testing
20. Brain organization of schizophrenics
21. Statistical parametric mapping in functional neuroimaging: Beyond PET and fMRI activation studies
22. Effects of repeated high-dose methamphetamine on local cerebral glucose utilization in rats
23. Dopamine-GABA interactions: Evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system
24. Addiction and imaging of the living human brain
25. Administration of excitatory amino acid antagonists via microdialysis attenuates the increase in glucose utilization seen following concussive brain injury
26. Hyperperfusion and hypermetabolism in brain radiation necrosis with epileptic activity
27. FDG hypermetabolism associated with inflammatory necrotic changes following radiation of meningioma
28. 18FDG-PET scan
29. Microgliosis and down-regulation of adenosine transporter induced by methamphetamine in rats
30. Methamphetamine (METH) causes reactive gliosis in vitro: Attenuation by the ADP-ribosylation (ADPR) inhibitor, benzamide
31. Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study
32. Effect of methamphetamine on glutamate-positive neurons in the adult and developing rat somatosensory cortex
33. Effects of high-dose methamphetamine on monoamine uptake sites in rat brain measured by quantitative autoradiography
34. Striatal and cortical NMDA receptors are altered by a neurotoxic regimen of methamphetamine
35. 18F]fluorodeoxyglucose and PET
36. The early diagnosis of Parkinson's disease
37. The metabolic topography of parkinsonism
38. Differential distribution of striatal [1231]beta-CIT in Parkinson's disease and progressive supranuclear palsy, evaluated with single-photon emission tomography
39. Immunochemical analysis of dopamine transporter protein in Parkinson's disease
40. 18)F]beta-CFT in assessing disability in Parkinson's disease
41. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography
42. High-dose methamphetamine treatment alters presynaptic GABA and glutamate immunoreactivity
43. 18F]FDG